BioCentury | Aug 31, 2018
Clinical News

MC2's non-greasy psoriasis cream superior to Taclonex in Phase III

...A/S (Horsholm, Denmark) said MC2-01, its non-greasy topical cream formulation of calcipotriene/betamethasone dipropionate, was superior to Taclonex...
...calcipotriene and betamethasone dipropionate that uses PAD technology Indication: Treat psoriasis Endpoint: Non-inferiority to Taclonex calcipotriene/betamethasone dipropionate...
...itch Status: Phase III data Milestone: Submit NDA (1H19) Jaime De Leon Daivobet, Dovobet, Dovonex, Taclonex, Xamiol, calcipotriene/betamethasone dipropionate MC2-01 Leo...
BioCentury | Aug 21, 2018
Clinical News

MC2's non-greasy psoriasis cream superior to Taclonex

...A/S (Horsholm, Denmark) said MC2-01, its non-greasy topical cream formulation of calcipotriene/betamethasone dipropionate, was superior to Taclonex...
...least two points from baseline on the Physician’s Global Assessment (PGA), at week eight vs. Taclonex...
...the scalp and body in patients 18 and older. Jaime De Leon Daivobet, Dovobet, Dovonex, Taclonex, Xamiol, calcipotriene/betamethasone dipropionate MC2-01 Leo...
BioCentury | May 2, 2016
Clinical News

Enstilar calcipotriene/betamethasone dipropionate aerosol foam regulatory update

...synthetic corticosteroid, is marketed in the U.S. Leo Pharma A/S , Ballerup, Denmark Product: Enstilar calcipotriene/betamethasone dipropionate...
BioCentury | Apr 11, 2016
Clinical News

Enstilar calcipotriene/betamethasone dipropionate aerosol foam regulatory update

...approved in the U.S. for the indication. Leo Pharma A/S , Ballerup, Denmark Product: Enstilar calcipotriene/betamethasone dipropionate...
BioCentury | Nov 2, 2015
Clinical News

Calcipotriene/betamethasone dipropionate aerosol foam regulatory update

...betamethasone dipropionate, a synthetic corticosteroid, early next year. Leo Pharma A/S , Ballerup, Denmark Product: Calcipotriene/betamethasone dipropionate...
BioCentury | Jun 15, 2015
Clinical News

Calcipotriene/betamethasone dipropionate aerosol foam: Phase III data

...FDA and an MAA to EMA for Enstilar. Leo Pharma A/S , Ballerup, Denmark Product: Calcipotriene/betamethasone dipropionate...
BioCentury | Feb 9, 2015
Clinical News

Calcipotriene/betamethasone dipropionate aerosol foam regulatory update

...Leo Pharma submitted an NDA to FDA for calcipotriene/betamethasone dipropionate aerosol foam to treat psoriasis vulgaris. The...
...markets the combination as an ointment called Taclonex Ointment and as a topical suspension called Taclonex...
...and other countries this year and in 2016. Leo Pharma A/S , Ballerup, Denmark Product: Calcipotriene/betamethasone dipropionate...
BioCentury | Oct 13, 2014
Company News

Leo Pharma sales and marketing update

...Leo Pharma's Leo Pharma Inc. subsidiary launched Taclonex calcipotriene/betamethasone dipropionate to treat plaque psoriasis of the scalp...
...more than 60 g per week, while adults should use no more than 100 g. Taclonex...
BioCentury | Sep 22, 2014
Company News

Kyowa Hakko Kirin, Leo Pharma sales and marketing update

...Dovobet Ointment calcipotriene/betamethasone dipropionate in Japan to treat psoriasis vulgaris. Leo Pharma is responsible for supplying Dovobet...
...treat psoriasis vulgaris in 97 countries, including under the name Taclonex in the U.S. and Xamiol...
BioCentury | Jul 14, 2014
Clinical News

Dovobet regulatory update

...Japan) said Japan’s Ministry of Health, Labor and Welfare (MHLW) approved Leo Pharma’s Dovobet Ointment calcipotriene/betamethasone dipropionate...
...treat psoriasis vulgaris in 97 countries, including under the name Taclonex in the U.S. and Xamiol...
...Ballerup, Denmark Product: Dovobet ( Taclonex , Xamiol - EU, Daivobet - EU, Dovonex ) calcipotriene/betamethasone dipropionate...
Items per page:
1 - 10 of 40